Melanocortin-pharmacology research domains for PT-141 with verifiable database links.
Where it appears
PT-141 appears across melanocortin-receptor pharmacology, GPCR-signaling and structure-activity research literature. As a tool agonist it is widely cited in studies mapping MC1R and MC4R behavior, and its approved-medicine status in some markets adds to its citation footprint.
How to survey the literature
Begin with the database links below, searching the full name Bremelanotide alongside melanocortin or MC4R to surface the most relevant primary studies for independent assessment.
Scope note
This material is supplied for research use only. Clinical information for the approved medicine pertains to regulated contexts elsewhere and is not part of this reference data.
Credible sources
- PubChem — Bremelanotide
- PubMed literature — Bremelanotide PT-141
- PubMed literature — melanocortin MC4R pharmacology
Research context only. This article summarizes published in-vitro and pre-clinical research for scientific context. It is not a claim of efficacy or safety and does not constitute medical, usage, or dosing guidance. Helix Reagents products are Research Use Only and not for human or veterinary use.